II. Veterans Affairs Cooperative Study of Polyenylphosphatidylcholine in Alcoholic Liver Disease

Alcoholism: Clinical and Experimental Research

Volumn 27, Issue 11, 2003, Pages 1765-1772

  Lieber, Charles S ^a,e   Weiss, David G ^b   Groszmann, Roberto ^c   Paronetto, Florenzo ^a   Schenker, Steven ^d  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Ascites; Cirrhosis; Phospholipids

Indexed keywords

ALANINE AMINOTRANSFERASE; BILIRUBIN; CHOLINE DERIVATIVE; PLACEBO; PLANT EXTRACT; POLYENE PHOSPHATIDYLCHOLINE; UNCLASSIFIED DRUG;

ADULT; ALCOHOL ABUSE; ALCOHOL CONSUMPTION; ALCOHOL LIVER DISEASE; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HEALTH CENTER; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER FIBROSIS; LIVER INJURY; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SOLDIER; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

ADULT; ANALYSIS OF VARIANCE; CHI-SQUARE DISTRIBUTION; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LIVER DISEASES, ALCOHOLIC; MALE; MIDDLE AGED; PHOSPHATIDYLCHOLINES; PROSPECTIVE STUDIES; UNITED STATES; UNITED STATES DEPARTMENT OF VETERANS AFFAIRS;

ANIMALIA; HEPATITIS C VIRUS;

EID: 0345256577     PISSN: 01456008     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ALC.0000093743.03049.80     Document Type: Article

References (36)

1. Abramson JL, Williams SA, Krumholz HM, Vaccarino V (2001) Moderate alcohol consumption and risk of heart failure among older persons. JAMA 285:1971-1977.
2. Arai M, Gordon ER, Lieber CS (1984) Decreased cytochrome oxidase activity in hepatic mitochondria after chronic ethanol consumption and the possible role of decreased cytochrome aa3 content and changes in phospholipids. Biochim Biophys Acta 797:320-327.
3. Austin GE, Jensen B, Leete J, DeL'Aune W, Bhatnagar J, Racine M, Braun JE (2000) Prevalence of hepatitis C virus seropositivity among hospitalized US Veterans. Am J Med Sci 319:353-359.
4. Bird GLA, Panos MZ, Polson R, Johnson R, Portman BP, Neuberger J, Williams R (1991) Activity of polyunsaturated phosphatidylcholine in HbsAg negative chronic active hepatitis and acute alcoholic hepatitis. Z Gastroenterol 29:21-24.
5. Bissell DM, Friedman SL, Maher JJ, Roll FJ (1990) Connective tissue biology and hepatic fibrosis: report of a conference. Hepatology 11: 488-498.
6. Chevallier M, Guerret S, Chossegros P, Gerard F, Grimaud J-A (1994) A histological semiquantitative scoring system for evaluation of hepatic fibrosis in needle liver biopsy specimens: comparison with morphometric studies. Hepatology 20:349-355.
7. Cope K, Risby T, Diehl AM (2000) Increased gastrointestinal ethanol production in obese mice: implications for fatty liver disease pathogenesis. Gastroenterology 119:1340-1347.
8. Donner A (1984) Approaches to sample size estimation in the design of clinical trials-a review. Stat Med 3:199-214.
9. Dufour MC (1999) What is moderate drinking? Defining "drinks" and drinking levels. Alcohol Res Health 23:5-14.
10. Feldman G (1995) Critical analysis of the methods used to morphologically quantify hepatic fibrosis. J Hepatol 22:49-54.
11. French SW, Ihrig TJ, Morin RJ (1970) Lipid composition of RBC ghosts, liver mitochondria and microsomes of ethanol-fed rats. Q J Stud Alcohol 31:801-809.
12. Friedman SL (1990) Acetaldehyde and alcoholic fibrogenesis: fuel to the fire, but not the spark (editorial). Hepatology 12:609-612.
13. Gordis E (1999) Alcohol and Coronary Heart Disease (Alcohol Alert No. 45). National Institute on Alcohol Abuse and Alcoholism, Rockville, MD.
14. Gundermann KJ, Schumacher R eds (1990) 50th Anniversary of Phospholipid Research (EPL). wbn-Verlag, Bingen/Rhein, Germany.
15. Haybittle JL (1971) Repeated assessment of results in clinical trials of cancer treatment. Br J Radiol 44:793-797.
16. Klatsky AL (2001) Should patients with heart disease drink alcohol? JAMA 285:2004-2006.
17. Kuntz E (1980) Pilot Studie mit Polyenylphosphatidylcholin bei schwere Leber Insuffizienz. Med Welt 40:1327-1329.
18. Lankisch MR, Imoto M, Layer P, DiMagno EP (2001) The effect of small amounts of alcohol on the clinical course of chronic pancreatitis. Mayo Clin Proc 76:242-251.
19. Lelbach WK (1975) Cirrhosis in the alcoholic and its relation to the volume of alcohol abuse. Ann NY Acad Sci 252:85-105.
20. Lieber CS (2001a) Beneficial effects of polyenylphosphatidylcholine (PPC) in alcoholic and non-alcoholic liver injury, in Proceedings of the Falk Workshop "Steatohepatitis (NASH and ASH) " Falk Symposium 121 Meeting (Leuschner U, James O, Dancygier H, eds), pp 343-361. Kluwer, London.
21. Lieber CS (2001b) Alcohol and hepatitis C. Alcohol Res Health 25:245-254.
22. Lieber CS, DeCarli LM, Mak KM, Kim C-I, Leo MA (1990) Attenuation of alcohol-induced hepatic fibrosis by polyunsaturated lecithin. Hepatology 12:1390-1398.
23. Lieber CS, Leo MA, Aleynik SI, Lowe N, Aleynik MK, Paronetto F (2000) Increased circulating level of dilinoleoylphosphatidylcholine is associated with protection against alcohol induced oxidative stress and liver fibrosis in man (abstract). Hepatology 32:386A.
24. Lieber CS, Robin SJ, Li J, DeCarli L, Mak KM, Fasulo JM, Leo MA (1994) Polyenylphosphatidylcholine protects against fibrosis and cirrhosis in the baboon. Gastroenterology 106:152-159.
25. Lieber CS, Weiss D, Groszmann R, Paronetto F, Schenker S, for the Veterans Affairs Cooperative Study Group 391 (2003) I. Veterans Administration Cooperative Study of polyenylphosphatidylcholine in alcoholic liver disease: effects on drinking behavior by nurse/physician teams. Alcohol Clin Exp Res 27:1757-1764.
26. Ma X, Zhao J, Lieber CS (1996) Polyenylphosphatidylcholine attenuates non-alcoholic hepatic fibrosis and accelerates its regression. J Hepatol 24:604-613.
27. Maher JJ, McGuire RF (1990) Extracellular matrix gene expression increases preferentially in rat lipocytes and sinusoidal endothelial cells during hepatic fibrosis in vivo. J Clin Invest 86:1641-1648.
28. Mukamal KJ, Maclure M, Muller JE, Sherwood JB, Mittleman MA (2001) Prior alcohol consumption and mortality following acute myocardial infarction. JAMA 285:1965-1970.
29. Niederau C, Strohmeyer G, Heinges T, Peter K, Göpfert E (1998) Polyunsaturated phosphatidyl-choline and interferon alpha for treatment of chronic hepatitis B and C: a multi-center, randomized, double-blind, placebo-controlled trial. Leich Study Group. Hepatogastroenterology 45:797-804.
30. Pessione F, Degos F, Marcellin P, Duchatelle V, Njapoum C, Martinot-Peignoux M, Degott C, Valla D, Erlinger S, Rueff B (1998) Effect of alcohol consumption on serum hepatitis C virus RNA and histological lesions in chronic hepatitis C. Hepatology 27:1717-1722.
31. Pilette C, Rousselet MC, Bedossa P, Chappard D, Oberti F, Rifflet H, Maiga MY, Gallois Y, Cales P (1998) Histopathological evaluation of liver fibrosis: quantitative image analysis vs. semi-quantitative scores. Comparison with serum markers. J Hepatol 28:439-446.
32. Poynard T, Bedossa P, Opolon P (1997) Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet 349:825-832.
33. Savolainen VT, Liesto K, Mannikko A, Penttila A, Karhunen PJ (1993) Alcohol consumption and alcoholic liver diseases: evidence of a threshold level of effects of ethanol. Alcohol Clin Exp Res 17:1112-1117.
34. Worner TM, Lieber CS (1985) Perivenular fibrosis as precursor lesion of cirrhosis. JAMA 254:627-630.
35. Yamada S, Mak KM, Lieber CS (1985) Chronic ethanol consumption alters rat liver plasma membranes and potentiates release of alkaline phosphatase. Gastroenterology 88:1799-1806.
36. Zhang M, Gong Y, Corbin I, Mellon A, Choy P, Uhanova J, Minuk GY (2000) Light ethanol consumption enhances liver regeneration after partial hepatectomy in rats. Gastroenterology 119:1333-1339.